InvestorsHub Logo
Followers 30
Posts 2792
Boards Moderated 3
Alias Born 10/24/2015

Re: None

Monday, 12/05/2022 8:08:11 PM

Monday, December 05, 2022 8:08:11 PM

Post# of 78
An Investor Day set for the 7th at 8:00 AM ET. It will provide preliminary data from the six-month follow-up of the first 75 patients enrolled in the IGNYTE clinical trial cohort of RP1 combined with Opdivo in anti-PD1 failed melanoma. Additionally, there will be an update on the RP2 and RP3 program as well.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent REPL News